Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IL-6 | 100 | ug/mL | 3 | SCF | 30.0 | 60 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | SCF | 34.0 | 63 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | SCF | 31.0 | 79 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | SCF | 31.0 | 65 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | SCF | 35.0 | 68 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | SCF | 36.0 | 72 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | SCF | 39.0 | 73 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | SCF | 72.0 | 73 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | SCF | 61.5 | 62 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | SCF | 52.0 | 56 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | SCF | 64.0 | 57 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | SCF | 46.0 | 60 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | SCF | 50.0 | 76 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | SCF | 61.0 | 72 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | SCF | 62.5 | 72 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCF | 63.0 | 65 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCF | 74.5 | 78 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCF | 81.0 | 72 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCF | 68.0 | 54 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCF | 44.0 | 74 | |
RA2159 | PI103 | 0.1 | uM | 3 | SCF | 36.0 | 76 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | SCF | 158.0 | 82 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCF | 212.0 | 61 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCF | 161.0 | 70 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCF | 205.0 | 59 |